An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
E GreimelEORTC Quality of Life Group and the Quality of Life Unit

Abstract

This study defines the psychometric properties of the European Organisation for Research and Treatment of Cancer (EORTC) quality of life (QOL) questionnaire designed to measure the QOL of patients with ovarian cancer. The ovarian cancer module (EORTC QLQ-OV28) was developed to supplement the EORTC QLQ-C30. The core questionnaire and the QLQ-OV28 were prospectively administered to 368 ovarian cancer patients after they had been treated with radical or debulking surgery followed by chemotherapy. The QLQ-OV28 module assesses abdominal/gastrointestinal symptoms, peripheral neuropathy, other chemotherapy side-effects, hormonal/menopausal symptoms, body image, attitude to disease/treatment and sexual functioning. Questionnaires were well accepted by patients, baseline compliance rates were 86%, 72% provided a second assessment, less than 3% of the items had missing data. Multi-trait scaling analyses confirmed the hypothesised scales. All hypothesised scales exhibited good psychometric properties. These results support the clinical and psychometric validity of the EORTC QLQ-OV28 module as a supplement to the EORTC QLQ-C30.

References

Oct 1, 1994·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·D OsobaJ Latreille
Apr 1, 1996·Hematology/oncology Clinics of North America·M J Thirman, R A Larson
May 1, 1996·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A MontazeriC R Gillis
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A CullUNKNOWN Scottish Gynaecological Cancer Trials Group

❮ Previous
Next ❯

Citations

Apr 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·G Borghede, M Sullivan
Sep 18, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Dominique KoensgenUNKNOWN Nord-Ostdeutschen Gesellschaft für Gynäkologische Onkologie (NOGGO) working group "Quality of life"
Aug 30, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lucas MinigDiana D Jeffery
Aug 9, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Clare HarleyGalina Velikova
Mar 13, 2012·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Bernhard HolznerJohannes M Giesinger
Dec 22, 2006·Nature Clinical Practice. Oncology·Charlotte C SunDiane C Bodurka
Dec 7, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M L Friedlander, M T King
Aug 18, 2004·Current Opinion in Oncology·Maxine L Stead
May 6, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Mark S CareyUNKNOWN Gynecologic Cancer InterGroup (GCIG)
Sep 14, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M S ManoM Piccart
Mar 31, 2011·Health and Quality of Life Outcomes·Johannes M GiesingerUNKNOWN European Organisation for Research and Treatment of Cancer Quality of Life Group (EORTC-QLG)
Mar 5, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Floortje K Ploos van AmstelPetronella B Ottevanger
Jul 10, 2014·Journal of the National Cancer Institute·Kristine A DonovanLari Wenzel
Feb 18, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Elfriede Greimel, Andrew John Nordin
Dec 21, 2013·Expert Review of Pharmacoeconomics & Outcomes Research·Jan ParadowskiAndrew Bottomley
Dec 14, 2011·Gynecologic Oncology·Chara StavrakaSarah Blagden
Jan 5, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·F PlottiR Angioli
Aug 8, 2014·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Ingunn AmbleBruce E Wampold
Jun 17, 2014·Journal of Korean Medical Science·Yumi LeeSang-Yoon Park
Feb 11, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Anke SmitsKhadra Galaal
Jan 17, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Floortje K Ploos van AmstelPetronella B Ottevanger
Nov 6, 2013·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Ingunn AmbleBruce E Wampold
Jan 4, 2006·American Journal of Obstetrics and Gynecology·Georgina L JonesStephen H Kennedy
May 21, 2013·Gynecologic Oncology·Mary H SailorsCharles S Cleeland
Apr 2, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin R StocklerEric Pujade-Lauraine
Aug 25, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andreas du BoisJalid Sehouli
Sep 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jacobus PfistererUNKNOWN EORTC GCG
Jun 24, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Remi A NoutCarien L Creutzberg
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley J MonkAndrés M Poveda
Mar 30, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Remi A NoutCarien L Creutzberg
Apr 12, 2017·Western Journal of Nursing Research·Minhae KimJi-Su Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.